BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32059125)

  • 1. Serum profile of IL-1β and IL-17 cytokines in patients with visceral leishmaniasis.
    Babaloo Z; Oskoei MR; Kohansal MH; Barac A; Ahmadpour E
    Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101431. PubMed ID: 32059125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance.
    Araújo-Santos T; Andrade BB; Gil-Santana L; Luz NF; Dos Santos PL; de Oliveira FA; Almeida ML; de Santana Campos RN; Bozza PT; Almeida RP; Borges VM
    Sci Rep; 2017 Jun; 7(1):4334. PubMed ID: 28659627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Th1 cytokines.
    Babaloo Z; Kaye PM; Eslami MB
    Trans R Soc Trop Med Hyg; 2001; 95(1):85-8. PubMed ID: 11280075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14.
    Dos Santos PL; de Oliveira FA; Santos ML; Cunha LC; Lino MT; de Oliveira MF; Bomfim MO; Silva AM; de Moura TR; de Jesus AR; Duthie MS; Reed SG; de Almeida RP
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004375. PubMed ID: 26814478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Multiplexed Assay for Detection of
    Abeijon C; Alves F; Monnerat S; Wasunna M; Mbui J; Viana AG; Bueno LL; Siqueira WF; Carvalho SG; Agrawal N; Fujiwara R; Sundar S; Campos-Neto A
    J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
    Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
    Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of serum cytokines and circulating microRNAs that are predicted to regulate inflammasome genes in cutaneous leishmaniasis patients.
    Mendonça LSO; Santos JM; Kaneto CM; de Carvalho LD; Lima-Santos J; Augusto DG; Carvalho SMS; Soares-Martins JAP; Silva-Jardim I
    Exp Parasitol; 2020 Mar; 210():107846. PubMed ID: 32001303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.
    Wolday D; Berhe N; Britton S; Akuffo H
    AIDS; 2000 May; 14(8):921-9. PubMed ID: 10853973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytokines associated with severity and complications of kala-azar.
    Costa DL; Rocha RL; Carvalho RM; Lima-Neto AS; Harhay MO; Costa CH; Barral-Neto M; Barral AP
    Pathog Glob Health; 2013 Mar; 107(2):78-87. PubMed ID: 23683334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole blood-based in vitro culture reveals diminished secretion of pro-inflammatory cytokines and chemokines in visceral leishmaniasis.
    Tasew G; Gadisa E; Abera A; Chanyalew M; Abebe M; Howe R; Ritter U; Aseffa A; Laskay T
    Cytokine; 2021 Sep; 145():155246. PubMed ID: 32828639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis.
    Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P
    Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a sandwich ELISA to detect Leishmania 40S ribosomal protein S12 antigen from blood samples of visceral leishmaniasis patients.
    Zhang WW; Ghosh AK; Mohamath R; Whittle J; Picone A; Lypaczewski P; Ndao M; Howard RF; Das P; Reed SG; Matlashewski G
    BMC Infect Dis; 2018 Oct; 18(1):500. PubMed ID: 30285653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling Cerebral Leishmaniasis: parasites and brain inflammation in Leishmania donovani infected mice.
    Melo GD; Goyard S; Fiette L; Boissonnas A; Combadiere C; Machado GF; Minoprio P; Lang T
    Sci Rep; 2017 Aug; 7(1):8454. PubMed ID: 28814754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
    Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
    Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.
    Hailu A; van der Poll T; Berhe N; Kager PA
    Am J Trop Med Hyg; 2004 Nov; 71(5):561-7. PubMed ID: 15569785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17A promotes susceptibility during experimental visceral leishmaniasis caused by Leishmania donovani.
    Terrazas C; Varikuti S; Kimble J; Moretti E; Boyaka PN; Satoskar AR
    FASEB J; 2016 Mar; 30(3):1135-43. PubMed ID: 26581600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of a rK39 homologue from an Iranian Leishmania infantum isolate in Leishmania tarentolae for serodiagnosis of visceral leishmaniasis.
    Rezaei Z; Van Reet N; Pouladfar G; Kühne V; Ramezani A; Sarkari B; Pourabbas B; Büscher P
    Parasit Vectors; 2019 Dec; 12(1):593. PubMed ID: 31852505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype.
    Kong F; Saldarriaga OA; Spratt H; Osorio EY; Travi BL; Luxon BA; Melby PC
    PLoS Pathog; 2017 Jan; 13(1):e1006165. PubMed ID: 28141856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.
    Das VNR; Bimal S; Siddiqui NA; Kumar A; Pandey K; Sinha SK; Topno RK; Mahentesh V; Singh AK; Lal CS; Singh SK; Das P
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008272. PubMed ID: 32555598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.